6446 — PHARMAESSENTIA Balance Sheet
0.000.00%
- TWD185.97bn
- TWD165.25bn
- TWD9.73bn
Annual balance sheet for PHARMAESSENTIA, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,212 | 3,454 | 11,280 | 19,688 | 21,075 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 451 | 493 | 840 | 1,548 | 2,832 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,147 | 4,927 | 13,375 | 22,896 | 25,417 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 903 | 780 | 1,045 | 2,836 | 3,560 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,531 | 6,198 | 15,333 | 27,269 | 31,062 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,087 | 1,412 | 2,550 | 2,152 | 2,557 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,611 | 1,948 | 3,191 | 3,321 | 3,593 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3,920 | 4,250 | 12,141 | 23,948 | 27,469 |
| Total Liabilities & Shareholders' Equity | 5,531 | 6,198 | 15,333 | 27,269 | 31,062 |
| Total Common Shares Outstanding |